Bravelle

DRUG3 trials

Sponsors

Glycotope GmbH, Ferring Pharmaceuticals, Instituto de Investigacion Sanitaria La Fe

Conditions

Female InfertilityInfertilityMale Infertility

Phase 1

Single Dose FSH-GEX™ in Healthy Volunteers

CompletedNCT01354886

Glycotope GmbHFemale Infertility

Start: 2011-04-30End: 2011-10-31Updated: 2021-05-11

Phase 3

Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia

TerminatedNCT02605070

Instituto de Investigacion Sanitaria La FeMale Infertility

Start: 2015-11-30End: 2017-06-13Updated: 2018-03-02

Phase 4

Menopur Mixed Protocol

CompletedNCT01417195

Ferring PharmaceuticalsInfertility

Start: 2011-07-31End: 2012-01-31Updated: 2014-05-16

Related Papers

A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.

2017-08-0116 citations